Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 68
  1. Jan 28, 2026 · 16:07 · LSL

    LSL obtains FDA certification for ophthalmic ointments

    LSL obtains FDA certification for ophthalmic ointments

    01
  2. Jan 28, 2026 · 08:40 · DTC

    Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline

    Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline

    02
  3. Jan 28, 2026 · 08:30 · CPH

    Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)

    Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba(TM) (Spinosad)

    03
  4. Jan 28, 2026 · 08:30 · AIAI

    NetraMark Closes First Tranche of Private Placement

    NetraMark Closes First Tranche of Private Placement

    04
  5. Jan 28, 2026 · 08:06 · VPT

    Ventripoint Issues Shares for Debt Settlement and Awards Option Grants

    Ventripoint Issues Shares for Debt Settlement and Awards Option Grants

    05
  6. Jan 28, 2026 · 08:01 · IZO

    Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement

    Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement

    06
  7. Jan 28, 2026 · 07:30 · BCT

    BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

    BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

    07
  8. Jan 28, 2026 · 07:00 · LSL

    LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES

    LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES

    08
  9. Jan 28, 2026 · 07:00 · MSCL

    Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing

    Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing

    09
  10. Jan 27, 2026 · 19:50 · INNO

    Innocan Pharma to list on NYSE American

    Innocan Pharma to list on NYSE American

    10
  11. Jan 27, 2026 · 19:27 · RKV

    Rakovina Therapeutics appoints Oishi as CEO, director

    Rakovina Therapeutics appoints Oishi as CEO, director

    11
  12. Jan 27, 2026 · 18:14 · NURS

    Hydreight closes $15-million bought deal

    Hydreight closes $15-million bought deal

    12
  13. Jan 27, 2026 · 17:53 · PHA

    Premier Health Reports 2025 Fourth Quarter Results

    Premier Health Reports 2025 Fourth Quarter Results

    13
  14. Jan 27, 2026 · 17:49 · MBIO

    Mindbio will analyze your voice, detect intoxication

    Mindbio will analyze your voice, detect intoxication

    14
← Newer Older →